首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Study of Drug-Drug Interactions in Prescriptions of General Practitioners and Specialists in Iran 2007-2009
【2h】

Study of Drug-Drug Interactions in Prescriptions of General Practitioners and Specialists in Iran 2007-2009

机译:2007-2009年伊朗全科医生和专家处方药中药物相互作用的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prescriptions written by general practitioners and medical specialists were studied and compared to determine the type, time of onset and clinical importance of drug-drug interactions (DDIs) in an attempt to reduce further complications.In 2007, 28, 956, 638 prescriptions and 15, 610, 912 prescriptions in 2008 were filled by pharmacies affiliated with medical science universities. These prescriptions, prescribed by physicians from 33 Iranian medical universities nationwide were then evaluated with a prescription processing software named Pardazesh Nosakh. After processing and analyzing the data, DDIs were discovered in 14 different medical specialists consisting of internists, cardiologists, neurologists, psychiatrists, neurosurgeons, general surgeons, infectious diseases, urologists, dermatologists, ENT, ophthalmologists, orthopedists, and pediatrician. The results were then analyzed through methods applied in the book of Drug Interaction Facts.The results revealed that in 2007-2008, 0.77% of prescriptions had DDIs out of which 0.67% were with significant clinical importance. The percentage of interactions with significant clinical importance was higher in prescriptions of medical specialists and of those, cardiologists and internists ranked top on the list, while dermatologists ranked the lowest. The most common interacting combination prescribed was digoxin and furosmide in 2007-2008, and captopril and triamteren in 2008-2009. Moreover, this study showed that polypharmacy was an important factor which led to DDIs. Drug interactions were common among outpatients prescribed multiple medications and the rate of DDIs increased with the number of drugs prescribed.It is our opinion that by being up-to-date on drug information and participating in related educational classes and workshops, physicians can increase the chances of choosing the correct drug treatment and hence significantly decrease possible DDIs side effects.
机译:研究和比较了由全科医生和医学专家撰写的处方,以确定药物-药物相互作用(DDI)的类型,发作时间和临床重要性,以减少进一步的并发症.2007年,共有28、956、638张处方和15张在2008年,共有610、912份处方由与医科大学相关的药房填写。然后,使用名为Pardazesh Nosakh的处方处理软件对来自全国33所伊朗医科大学的医师开出的这些处方进行评估。在对数据进行处理和分析之后,在14位不同的医学专家中发现了DDI,这些专家包括内科医生,心脏病专家,神经病学家,精神病医生,神经外科医师,普通外科医生,传染病,泌尿科医师,皮肤科医生,耳鼻喉科,眼科医生,骨科医生和儿科医生。然后通过《药物相互作用事实》(Drug Interaction Facts)一书中使用的方法对结果进行分析。结果表明,在2007-2008年,有0.77%的处方具有DDI,其中0.67%具有重要的临床意义。在医学专家的处方中,具有重要临床意义的相互作用百分比更高,其中心脏病专家和内科医生排名最高,而皮肤科医生排名最低。处方中最常见的相互作用组合是2007-2008年的地高辛和呋塞米,以及2008-2009年的卡托普利和氨苯蝶呤。此外,这项研究表明,多元药房是导致DDI的重要因素。在处方多种药物的门诊患者中,药物相互作用很普遍,DDIs的比率随处方药物的数量而增加。我们认为,通过了解药物信息的最新情况并参加相关的教育课程和讲习班,医生可以增加药物相互作用。选择正确药物治疗的机会,从而显着降低可能的DDI副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号